4//SEC Filing
Oliviero James F III 4
Accession 0001104659-24-010265
CIK 0001651407other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:10 PM ET
Size
7.5 KB
Accession
0001104659-24-010265
Insider Transaction Report
Form 4
Oliviero James F III
DirectorCEO, President and Director
Transactions
- Sale
COMMON STOCK
2024-02-01$2.01/sh−11,900$23,919→ 369,680 total - Gift
COMMON STOCK
2024-02-01−12,950→ 356,730 total
Footnotes (4)
- [F1]In connection with the vesting of 24,850 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- [F2]Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $2.00 to $2.0104. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes shares of restricted common stock, which vest over various time periods.
- [F4]On February 1, 2024, 12,950 shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Oliviero's minor children. Mr. Oliviero is not a trustee of the trust and has no investment control over the securities held by the trust.
Documents
Issuer
Checkpoint Therapeutics, Inc.
CIK 0001651407
Entity typeother
Related Parties
1- filerCIK 0001434718
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 8:10 PM ET
- Size
- 7.5 KB